US 8148328
Salicylanilides enhance oral delivery of therapeutic peptides
granted A61KA61K31/165A61K38/03
Quick answer
US patent 8148328 (Salicylanilides enhance oral delivery of therapeutic peptides) held by The Regents of the University of California expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/165, A61K38/03, A61K38/04, A61K38/16